{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T18:12:43Z","timestamp":1759774363467},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2017,9,7]],"date-time":"2017-09-07T00:00:00Z","timestamp":1504742400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"First Affiliated Hospital of Xi\u2019an Jiaotong University fund 2013","award":["2013YK43"],"award-info":[{"award-number":["2013YK43"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s11010-017-3183-x","type":"journal-article","created":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T19:53:58Z","timestamp":1505159638000},"page":"173-179","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effects of VEGF levels on anti-VEGF therapy for patients with idiopathic choroidal neovascularization"],"prefix":"10.1007","volume":"441","author":[{"given":"Xiaojuan","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianqin","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianyan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,7]]},"reference":[{"issue":"5","key":"3183_CR1","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0161-6420(95)30968-2","volume":"102","author":"AC Ho","year":"1995","unstructured":"Ho AC, Yannuzzi LA, Pisicano K, DeRosa J (1995) The natural history of idiopathic subfoveal choroidal neovascularization. Ophthalmology 102(5):782\u2013789","journal-title":"Ophthalmology"},{"issue":"10","key":"3183_CR2","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0161-6420(13)30854-9","volume":"102","author":"P Lempert","year":"1995","unstructured":"Lempert P (1995) Idiopathic subfoveal choroidal neovascularization. Ophthalmology 102(10):1411\u20131412","journal-title":"Ophthalmology"},{"issue":"9","key":"3183_CR3","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/archopht.1983.01040020360003","volume":"101","author":"Argon laser photocoagulation for idiopathic neovascularization","year":"1983","unstructured":"Argon laser photocoagulation for idiopathic neovascularization (1983) Results of a randomized clinical trial. Arch Ophthalmol 101(9):1358\u20131361","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"3183_CR4","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1442-9071.2006.01179.x","volume":"34","author":"F Sii","year":"2006","unstructured":"Sii F, Lee LR (2006) Retinopathy associated with photodynamic therapy for treatment of idiopathic choroidal neovascularization. Clin Exp Ophthalmol 34(2):184\u2013186","journal-title":"Clin Exp Ophthalmol"},{"issue":"4","key":"3183_CR5","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ajo.2006.04.028","volume":"142","author":"V Isola","year":"2006","unstructured":"Isola V, Pece A, Parodi MB (2006) Choroidal ischemia after photodynamic therapy with verteporfin for choroidal neovascularization. Am J Ophthalmol 142(4):680\u2013683","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"3183_CR6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ajo.2012.10.010","volume":"155","author":"HM Kang","year":"2013","unstructured":"Kang HM, Koh HJ (2013) Intravitreal anti-vascular endothelial growth factor therapy versus photodynamic therapy for idiopathic choroidal neovascularization. Am J Ophthalmol 155(4):713\u2013719","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"3183_CR7","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.3760\/cma.j.issn.0366-6999.20140544","volume":"127","author":"X Shi","year":"2014","unstructured":"Shi X, Wei W, Zhang C (2014) Intravitreal ranibizumab therapy versus photodynamic therapy for idiopathic choroidal neovascularization: a comparative study on visual acuity, retinal and choroidal thickness. Chin Med J 127(12):2279\u20132285","journal-title":"Chin Med J"},{"key":"3183_CR8","doi-asserted-by":"crossref","unstructured":"Carreno E, Moutray T, Fotis K, Lee RW, Dick AD, Ross AH, et al. (2015) Phase IIb clinical trial of ranibizumab for the treatment of uveitic and idiopathic choroidal neovascular membranes. Br J Ophthalmol","DOI":"10.1136\/bjophthalmol-2015-307806"},{"issue":"3","key":"3183_CR9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.5301\/ejo.5000691","volume":"26","author":"P Zhou","year":"2016","unstructured":"Zhou P, Yang L, Jin X (2016) Ranibizumab versus bevacizumab for the treatment of idiopathic choroidal neovascularization: 2-year results. Eur J Ophthalmol 26(3):262\u2013267","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"3183_CR10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/IAE.0000000000000354","volume":"35","author":"H Kim","year":"2015","unstructured":"Kim H, Lee K, Lee CS, Byeon SH, Lee SC (2015) Subfoveal choroidal thickness in idiopathic choroidal neovascularization and treatment outcomes after intravitreal bevacizumab therapy. Retina 35(3):481\u2013486","journal-title":"Retina"},{"issue":"11","key":"3183_CR11","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/archopht.125.11.1487","volume":"125","author":"S Mandal","year":"2007","unstructured":"Mandal S, Garg S, Venkatesh P, Mithal C, Vohra R, Mehrotra A (2007) Intravitreal bevacizumab for subfoveal idiopathic choroidal neovascularization. Arch Ophthalmol 125(11):1487\u20131492","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"3183_CR12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.preteyeres.2010.09.003","volume":"30","author":"E Stefansson","year":"2011","unstructured":"Stefansson E, Geirsdottir A, Sigurdsson H (2011) Metabolic physiology in age related macular degeneration. Prog Retinal Eye Res 30(1):72\u201380","journal-title":"Prog Retinal Eye Res"},{"key":"3183_CR13","first-page":"3512","volume":"17","author":"X Wankun","year":"2011","unstructured":"Wankun X, Wenzhen Y, Min Z, Weiyan Z, Huan C, Wei D et al (2011) Protective effect of paeoniflorin against oxidative stress in human retinal pigment epithelium in vitro. Mol Vis 17:3512\u20133522","journal-title":"Mol Vis"},{"issue":"5","key":"3183_CR14","doi-asserted-by":"crossref","first-page":"e0125150","DOI":"10.1371\/journal.pone.0125150","volume":"10","author":"M Zhao","year":"2015","unstructured":"Zhao M, Bai Y, Xie W, Shi X, Li F, Yang F et al (2015) Interleukin-1beta level is increased in vitreous of patients with neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV). PLoS ONE 10(5):e0125150","journal-title":"PLoS ONE"},{"key":"3183_CR15","first-page":"574","volume":"18","author":"H Miao","year":"2012","unstructured":"Miao H, Tao Y, Li XX (2012) Inflammatory cytokines in aqueous humor of patients with choroidal neovascularization. Mol Vis 18:574\u2013580","journal-title":"Mol Vis"},{"issue":"2","key":"3183_CR16","first-page":"271","volume":"9","author":"SN Shah","year":"2016","unstructured":"Shah SN, Kang QY, Fan XJ, Sun YM (2016) Optical coherence tomography characteristics of responses to intravitreal bevacizumab in idiopathic choroidal neovascularization. Int J Ophthalmol 9(2):271\u2013274","journal-title":"Int J Ophthalmol"},{"issue":"2","key":"3183_CR17","first-page":"259","volume":"27","author":"SN Shah","year":"2015","unstructured":"Shah SN, Kang QY, Fan XJ, Shahbaz F (2015) Microstructural effects of intravitreal bevacizumab in idiopathic choroidal neovascularisation. J Ayub Med Coll 27(2):259\u2013263","journal-title":"J Ayub Med Coll"},{"issue":"7","key":"3183_CR18","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1097\/IAE.0000000000000491","volume":"35","author":"A Sudhalkar","year":"2015","unstructured":"Sudhalkar A, Yogi R, Chhablani J (2015) Anti-vascular endothelial growth factor therapy for naive idiopathic choroidal neovascularization: a comparative study. Retina 35(7):1368\u20131374","journal-title":"Retina"},{"issue":"12","key":"3183_CR19","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1016\/j.ophtha.2009.05.039","volume":"116","author":"M Funk","year":"2009","unstructured":"Funk M, Karl D, Georgopoulos M, Benesch T, Sacu S, Polak K et al (2009) Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab. Ophthalmology 116(12):2393\u20132399","journal-title":"Ophthalmology"},{"issue":"8","key":"3183_CR20","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/aos.12770","volume":"93","author":"S Fauser","year":"2015","unstructured":"Fauser S, Viebahn U, Muether PS (2015) Intraocular and systemic inflammation-related cytokines during one year of ranibizumab treatment for neovascular age-related macular degeneration. Acta Ophthalmol 93(8):734\u2013738","journal-title":"Acta Ophthalmol"},{"issue":"9","key":"3183_CR21","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1097\/IAE.0b013e318285cd9e","volume":"33","author":"PS Muether","year":"2013","unstructured":"Muether PS, Neuhann I, Buhl C, Hermann MM, Kirchhof B, Fauser S (2013) Intraocular growth factors and cytokines in patients with dry and neovascular age-related macular degeneration. Retina 33(9):1809\u20131814","journal-title":"Retina"},{"issue":"1","key":"3183_CR22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000365487","volume":"53","author":"Y Sakurada","year":"2015","unstructured":"Sakurada Y, Nakamura Y, Yoneyama S, Mabuchi F, Gotoh T, Tateno Y et al (2015) Aqueous humor cytokine levels in patients with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration. Ophthalmic Res 53(1):2\u20137","journal-title":"Ophthalmic Res"},{"issue":"10","key":"3183_CR23","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/archophthalmol.2010.227","volume":"128","author":"JB Jonas","year":"2010","unstructured":"Jonas JB, Tao Y, Neumaier M, Findeisen P (2010) Monocyte chemoattractant protein 1, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 in exudative age-related macular degeneration. Arch Ophthalmol 128(10):1281\u20131286","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"3183_CR24","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/IAE.0b013e318195cb15","volume":"29","author":"MI Roh","year":"2009","unstructured":"Roh MI, Kim HS, Song JH, Lim JB, Koh HJ, Kwon OW (2009) Concentration of cytokines in the aqueous humor of patients with naive, recurrent and regressed CNV associated with AMD after bevacizumab treatment. Retina 29(4):523\u2013529","journal-title":"Retina"},{"issue":"9","key":"3183_CR25","first-page":"1929","volume":"37","author":"A Kvanta","year":"1996","unstructured":"Kvanta A, Algvere PV, Berglin L, Seregard S (1996) Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci 37(9):1929\u20131934","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-017-3183-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-017-3183-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-017-3183-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T21:27:14Z","timestamp":1719437234000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-017-3183-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,7]]},"references-count":25,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["3183"],"URL":"https:\/\/doi.org\/10.1007\/s11010-017-3183-x","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,7]]}}}